DARREN HAMMERGREN: Open Payments
NPI 1386669885 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 37 payments from 9 companies in 2025. Trend: 2023 $901 · 2024 $797 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $145 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Bausch Health US, LLC | 1 | $23 |
| Alkermes, Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, INGREZZA, FANAPT, TRINTELLIX, AUSTEDO XR, APLENZIN.
Industry payments across AZ — which companies pay providers there.
